MedTrace Logo

The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes

NCT00678522 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2008-05-15

No results posted yet for this study

Summary

We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium excretion, glomerular filtration rate, tubular function and vasoactive hormones in patients with type II diabetes, not in treatment with insulin.

Conditions

  • Healthy Subjects

Interventions

DRUG

Atorvastatin

80 mg atorvastatin daily on two following days

Sponsors & Collaborators

  • Medical Research

    collaborator AMBIG

  • Regional Hospital Holstebro

    lead OTHER

Principal Investigators

  • Erling B. Pedersen, Professor · Dept. of medical reaserch, Holstebro Hospital, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00678522 on ClinicalTrials.gov